[1]TROJANO G,OLIVIERI C,TINELLI R,et al.Conservative treatment in early stage endometrial cancer:a review[J].Acta Biomed,2019,90(4):405-410.
[2]WU B,REN A,TIAN Y,et al.Hsa_circ_0075960 serves as a sponge for miR-361-3p/SH2B1 in endometrial carcinoma[J].Technol Cancer Res Treat,2020,19:1533033820983079.
[3]陈晨晨,彭存旭,吕艳华.miR-193b与子宫内膜癌临床病理表现的关系及其对化疗敏感性的影响研究[J].中国优生与遗传杂志,2022,30(3):446-451.
CHEN CC,PENG CX,LYU YH.Relationship between miR-193b and clinicopathological features of endometrial carcinoma and its effect on chemosensitivity[J].Chinese Journal of Birth Health & Heredity,2022,30(3):446-451.
[4]CHEN L,LI Y,LU J.Identification of circulating miR-762 as a nvel Diagnostic and prognostic biomarker for non-small cell lung cancer[J].Technol Cancer Res Treat,2020,19:1533033820964222.
[5]HOU R,YANG Z,WANG S,et al.miR-762 can negatively regulate menin in ovarian cancer[J].Onco Targets Ther,2017,10:2127-2137.
[6]LI Y,HUANG R,WANG L,et al.microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression[J].Cell Prolif,2015,48(6):643-649.
[7]LAI PS,CHANG WM,CHEN YY,et al.Circulating microRNA-762 upregulation in colorectal cancer may be accompanied by Wnt-1/β-catenin signaling[J].Cancer Biomark,2021,32(2):111-122.
[8]LIN G,SHENG H,XIE H,et al.circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762[J].Oncol Lett,2019,17(3):3537-3547.
[9]GE P,CAO L,CHEN X,et al.miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer[J].BMC Cancer,2019,19(1):1203.
[10]焦志凯,张越山,冯宁宁,等.微小RNA-762对胰腺癌PANC-1细胞株吉西他滨耐药性的影响[J].中华实验外科杂志,2020,37(1):15-18.
JIAO ZK,ZHANG YS,FENG NN,et al.Effect of microRNA-762 on the drug resistance to gemcitabine of pancreatic cancer PANC-1 cell line[J].Chinese Journal of Experimental Surgery,2020,37(1):15-18.
[11]SUN Y,TIAN H,XU X,et al.Low expression of adenomatous polyposis coli 2 correlates with aggressive features and poor prognosis in colorectal cancer[J].Bioengineered,2020,11(1):1027-1033.
[12]DONG Y,WU B,WANG X,et al.High miR-3648 expression and low APC2 expression are associated with shorter survival and tumor progression in NSCLC[J].Histol Histopathol,2022,37(4):355-364.
[13]DAI B,KONG DL,TIAN J,et al.microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma[J].Eur Rev Med Pharmacol Sci,2019,23(3):1125-1133.
[14]YING X,LI YQ,FENG Z,et al.MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression[J].Biomed Pharmacother,2015,71:64-69.
[15]WU Z,SHI W,JIANG C.Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/beta-catenin pathway by regulating miR-1205/APC2 axis[J].Biochem Biophys Res Commun,2018,502:465-471.
[16]TANWAR PS,ZHANG L,ROBERTS DJ,et al.Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer[J].Cancer Res,2011,71(5):1584-1596.
[17]MOHANMED NE,HAY T,REED KR,et al.APC2 is critical for ovarian WNT signalling control,fertility and tumour suppression[J].BMC Cancer,2019,19(1):677.
[18]MENG F,LIU X,LIN C,et al.SMYD2 suppresses APC2 expression to activate the Wnt/β-catenin pathway and promotes epithelial-mesenchymal transition in colorectal cancer[J].Am J Cancer Res,2020,10(3):997-1011.
[19]ZHANG W,RUAN X,LI Y,et al.KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway[J].Theranostics,2022,12(4):1500-1517.